US Patent Issued to GEORGETOWN UNIVERSITY on Oct. 28 for "Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor" (Maryland, Pennsylvania, Virginia, District Of Columbia Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,735, issued on Oct. 28, was assigned to GEORGETOWN UNIVERSITY (Washington).

"Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor" was invented by Jill P. Smith (Camp Hill, Pa.), Louis Weiner (Washington), Sandra Jablonski (Silver Spring, Md.), Sandeep Nadella (Alexandria, Va.) and Shangzi Wang (Derwood, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for treating a cholecystokinin (CCK) receptor-expressing cancerous tumor in a subject. The methods comprising administering to the subject an effective amount of a CCK receptor inhibitor and an effective amount of an immune checkpoint inhibitor...